Product category:
Liquid Analysis: Spectroscopy, Colour
News Release from: Avacta Group | Subject: MoD contract
Edited by the Processingtalk Editorial
Team on 21 December 2007
Detection of liquid chemicals by
spectroscopy
Development contract with the MoD Defence science and technology laboratory for the detection of liquid chemicals by laser spectroscopy
Avacta Group, which develops detection and analysis technology aimed at the defence and security, pharmaceutical and clinical diagnostics markets, announces a contract with the Defence science and technology laboratory (Dstl), which is part of the UK Ministry of Defence Avacta is developing methods of analysing liquids using laser spectroscopy
This article was originally published on Processingtalk on 19 Feb 2003 at 8.00am (UK)
Related stories
Oven temperature controllers
ABB Automation Technologies has supplied 12 ControlIT C351 single loop process controllers to Belgian chemical company Tessenderlo Chemie NV, to control six ovens in a continuous sulphate process
ABB adds single input versions to analyser range
ABB has launched single input versions of its AnalyzeIT AX400 pH/Redox and Conductivity analysers, with three alarm set points as standard
The goal is to enable the rapid detection of liquids in the field.
Professor Alastair Smith, Chief Executive, Avacta, commented: "We are delighted with the new contract for the development of a robust, prototype device.
Laser detection and diagnostic devices are a key part of the Avacta portfolio of technologies and this contract with the MoD is an important step for the company".
Avacta was spun-out from the University of Leeds in 2004 by its current management team as a biophysics company, with the aim of combining the disciplines of physics and biology to develop innovative technologies and expert technical services to address needs in the pharmaceutical, defence and clinical diagnostics markets.
Avacta has a core bio-analytical technology development programme addressing the needs of the biopharmaceutical sector to fully characterise their new products at the earliest stage in their development to reduce the risk of late stage failure.
High value solutions in defence and clinical diagnostics are also being provided by the Avacta development programmes.
A successful and growing part of the Avacta business model is its technical services arm, Avacta Analytical which is focused on providing leading edge contract research to the biopharmaceutical and healthcare/personal-care materials sectors.
Avacta listed on AIM in August 2006.
• Avacta Group: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
